Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single-dose GZR4

NCT06548815 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

43

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes

Interventions

DRUG: GZR4
DRUG: Placebo

Sponsor

Gan and Lee Pharmaceuticals, USA